Mon.Jul 25, 2022

article thumbnail

AstraZeneca, Daiichi breast cancer drug set for speedy FDA review

Bio Pharma Dive

The agency agreed to quickly assess the companies’ drug Enhertu for “HER2 low” metastatic breast cancer, an indication for which it could become the first targeted treatment option.

Drugs 320
article thumbnail

Embracing digitalization in the pharmaceutical supply chain

Pharmaceutical Technology

The COVID-19 pandemic triggered significant changes to the way healthcare operates. Digitalization is now in full swing as medical care integrates with ICT to take the patient experience to the next level. According to Tom Lenaerts, Head of Global Process Engineering at Datwyler, this transformation will reshape the entire healthcare ecosystem. “There are already opportunities for patients to track their health through smart medical devices sending reports directly to their healthcare provider.

Engineer 286
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novartis asks FDA to approve biosimilar for Biogen's top-selling MS drug

Bio Pharma Dive

Biogen will try to enforce patents protecting Tysabri, but an executive last week acknowledged that copycat drugs could launch when approved in the U.S.

Drugs 286
article thumbnail

Machine learning hiring levels in the pharmaceutical industry rose in June 2022

Pharmaceutical Technology

The proportion of pharmaceutical companies hiring for machine learning related positions rose in June 2022 compared with the equivalent month last year, with 26.4% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 24.1% of companies who were hiring for machine learning related jobs a year ago and an increase compared to the figure of 26.3% in May 2022.

233
233
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

China-based biotech licenses Sanofi's RNA drug technology

Bio Pharma Dive

The Lilly-backed Rona Therapeutics gains rights to a platform for small interfering RNA, along with a slate of preclinical candidates aimed at targets in the liver and other tissues.

RNA 246
article thumbnail

EMA CHMP recommends Moderna’s Covid-19 booster for adolescents

Pharmaceutical Technology

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an update to the conditional marketing authorization (CMA) to include Moderna ’s 50µg booster dose of Covid-19 vaccine, Spikevax, for usage in adolescents aged 12 to 17 years. As per the recommendation, the booster shot is indicated for use in people of this age group a minimum of three months after they receive the initial vaccine regimen.

More Trending

article thumbnail

Apptronik Launches Humanoid Robot

Pharmaceutical Technology

Concept: Austin-based robotics startup Apptronik has unveiled a humanoid robot named Astro. It is a general-purpose robot that can work alongside humans. Nature of Disruption: Astro is a human-centered robotic system that includes vision-based grasping. It leverages ML technology to find, grab and pick up objects. The robot has modern actuation packed into a small form factor.

article thumbnail

Next-level quality control in cell and gene therapy

Bio Pharma Dive

Discover examples of how Droplet Digital™ PCR (ddPCR™) is enabling cell and gene therapies to reach further than ever before.

article thumbnail

AstraZeneca-Daiichi Sankyo’s breast cancer ADC gets FDA priority review

Pharmaceutical Technology

AstraZeneca and Daiichi Sankyo have received Priority Review for their supplemental Biologics License Application (sBLA) from the US Food and Drug Administration (FDA) of antibody-drug conjugate (ADC), Enhertu (trastuzumab deruxtecan), to treat unresectable or metastatic HER2-low breast cancer in adults. The treatment is intended for HER2-low immunohistochemistry [IHC] 1+ or IHC 2+/in-situ hybridisation [ISH]-negative breast cancer patients who have previously received treatment in the metastati

HR 130
article thumbnail

Amazon will see you now: reading between the lines of the One Medical acquisition

Bio Pharma Dive

The deal’s near-term effects might not be large, but Amazon’s acquisition still threaten’s One Medical’s primary care competitors and others seeking a greater slice of the market, experts said.

Marketing 130
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

EC extends marketing authorisation for Bavarian Nordic’s smallpox vaccine

Pharmaceutical Technology

The European Commission (EC) has extended Bavarian Nordic ’s smallpox vaccine Imvanex (MVA-BN or Modified Vaccinia Ankara-Bavarian Nordic) marketing authorisation to offer protection from monkeypox. A non-replicating smallpox vaccine, Imvanex was developed in partnership with the US Government. The move to expand the marketing authorization for Imvanex to include protection from monkeypox and disease caused by the vaccinia virus comes after the European Medicines Agency (EMA) Committee for Medic

article thumbnail

Epidemiologists warn the U.S. reaches a critical moment to contain monkeypox

NPR Health - Shots

Cases in the U.S. are 10 times higher than they were a month ago. Researchers advise that the coming days and weeks will be crucial as to whether the outbreak can be contained.

article thumbnail

Philips on designing innovation and cultivating partnerships – part one

pharmaphorum

Sachin Grover, lead of solutions vertical at Philips India, tells me about the company’s innovations during India’s COVID outbreak and how they’ve led to increased healthcare access in the region. There is a vast difference in India’s healthcare system between rural and urban areas, but Philips’ team in the region is working hard to close that gap and improve access to healthcare. “It’s been 75 years since India’s independence.

article thumbnail

Corporate America reckons with its role in reproductive rights

NPR Health - Shots

A growing list of companies is offering to cover travel expenses for abortion care, if an employee lives in a state with restrictive laws. Yet corporate America still has its own issues to address.

129
129
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

STAT+: Four brain-computer interface companies you should watch (other than Neuralink)

STAT News

The term “brain-computer interface,” or BCI, has been buzzing around Silicon Valley and the mainstream media for years, thanks in part to Elon Musk’s secretive, yet flashy company Neuralink , which launched in 2017 with the promise of brain enhancement, telepathy, and similar sci-fi dreams of brain control. Neuralink, though, is one of the youngest players in the BCI field.

119
119
article thumbnail

Monkeypox FAQ: How contagious? Are kids at risk? If you had chickenpox are you safe?

NPR Health - Shots

In the wake of the World Health Organization's declaration of a public health emergency, there are many pressing questions. Here's what we know — and don't yet know — about monkeypox.

128
128
article thumbnail

Human element important for decentralized trial advancement

Outsourcing Pharma

During the Decentralized Trial Technology event, experts from CVS Health, University of Chicago, and ACRP shared insight on what can increase DCT success.

Trials 121
article thumbnail

How a near-death experience could change the way you live

NPR Health - Shots

When Randy Schiefer was hospitalized with COVID-19, he wasn't sure he would survive. Now, he looks back at that experience as the most important thing that has ever happened to him.

115
115
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

New studies offer theory on cause of unusual hepatitis cases in kids

STAT News

There is a new theory about what may be causing  puzzling cases  of pediatric hepatitis of unknown origin — and it is complex. Two new and as-yet-unpublished studies from scientists in the United Kingdom theorize that children who have developed the hepatitis cases may have been co-infected with two different viruses and had a genetic predisposition to have an over-exuberant immune response when that happened.

article thumbnail

5 things to know about the FDA's flawed approach to accelerated drug approvals

NPR Health - Shots

An NPR investigation found stalled confirmatory trials and lax enforcement are plaguing the FDA's accelerated approval of drugs for urgent medical needs.

Drugs 115
article thumbnail

Two deadly days in St. Louis: An overdose cluster kills 8 Black people — and shows the new shape of the addiction crisis

STAT News

ST. LOUIS — The calls for help poured in throughout the day: Overdose after overdose at the Parkview Apartments here, a double-winged complex with red brick capping the ends. Six people died that day this past February, five in this building and one at another apartment half a block away. Two others survived their overdoses, according to police.

105
105
article thumbnail

Bavarian Nordic’s smallpox vaccine approved for use against monkeypox in Europe

BioPharma Reporter

The European Commission has extended the marketing authorization for Bavarian Nordicâs smallpox vaccine, Imvanex, to include protection from monkeypox and disease caused by vaccinia virus.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Opinion: Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals

STAT News

Psychedelic medicine is having a moment of tremendous growth and innovation as researchers rediscover its potential mental health benefits. Although numerous biopharmaceutical companies are aiming to capitalize on these age-old therapies, many of them are leaving behind the Indigenous communities that pioneered the use of these medicines, have successfully used them for generations, and continue to have significant expertise in the area.

article thumbnail

The role of independent funds to help people access abortion is growing

NPR Health - Shots

Independent funds that help people pay for abortions have been flooded with donations since Roe v. Wade was overturned, but demand and costs are also rising as more states enact restrictive bans. (Image credit: Armando L.

105
105
article thumbnail

Opinion: Demanding more impact from impact litigation: lessons to be learned from multi-state opioid settlements

STAT News

In the 1990s, state Attorneys General learned how to leverage their resources when they retained private counsel to sue the tobacco industry. The private attorneys worked on contingency, meaning they did not get paid unless money was recovered from the tobacco industry. For their part, the states were able to take on novel litigation and draw from private investments in legal innovation without putting taxpayer dollars at risk.

article thumbnail

Roche’s fast-growing eye drug Vabysmo set for EU approval

pharmaphorum

Roche has been trumpeting the rapid uptake of its new eye disease drug Vabysmo as it takes on Regeneron and Bayer’s mighty Eylea in the US – and could soon start making inroads against its rival in Europe. Vabysmo (faricimab) has been recommended by the EMA’s human medicines committee as a treatment for neovascular or wet age-related macular degeneration (AMD) and diabetic macular oedema (DME), so could be fully approved and ready to roll out in the next few months, subject to pricin

Drugs 99
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

STAT+: A troubling report on Cerner’s VA rollout offers a rare look into the hidden harms of health records

STAT News

The rollout of Cerner’s electronic health record in Veterans Affairs hospitals has been a high-profile struggle: outages, training troubles, and now, an alarming report showing it directly harmed scores of patients. And while the system’s stumbles are noteworthy, they’re far from rare. Across the country, health systems large and small are engaged in the work of tweaking and transitioning between electronic health records.

98
article thumbnail

Atopic dermatitis research round-up

Antidote

Atopic dermatitis is a type of eczema, a skin condition caused by an overactive immune system that can lead to redness, blotchiness, and itching, typically on the face, arms, and legs. Atopic dermatitis is the most common type of eczema , impacting more than 9.6 million children and 16.5 million adults worldwide.

article thumbnail

Collateral damage of the Fed’s interest rate hikes: People who put medical bills on credit cards

STAT News

Tiffany Yarina didn’t max out her credit card from a home renovation or luxury purchase. It was from cancer. In 2005, Yarina started losing a lot of weight and watched her tonsils swell. Her doctors eventually diagnosed her with non-Hodgkin’s lymphoma. She needed chemotherapy and a tonsillectomy — but she had no health insurance.

Doctors 98
article thumbnail

The WHO declares monkeypox a public health emergency as cases pass 16,000 worldwide

NPR Health - Shots

The World Health Organization has declared monkeypox a public health emergency of global concern. Here's what that means and where the U.S. stands in terms of treatments and vaccines.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.